Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II pemetrexed monotherapy in heavily pretreated advanced breast cancer
ChiCTR-TNC-09000349Phase 2Completed
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pemetrexed in breast cancer, sponsored by Zhejiang Cancer Hospital. Primary endpoint: Objective response rate. Started Feb 2009; status: completed.
02
Drugs
pemetrexed
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR-TNC-09000349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-09000349.